GlassScriptPhysician profile
Grant Frederick Swanson
NPI 1477965861
$425.64
in general payments reported to CMS, 2019-2025
5 companies · $99.55 in 2025
The $99.55 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.50 · 2021: $160 · 2023: $99.95 · 2024: $17.64 · 2025: $99.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $200 · Food and Beverage: $17.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $199.50 |
| Food and Beverage | $17.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $160.00 | 2021 | |
| Astellas Pharma US INC | $99.95 | 2023 | |
| Lilly USA, LLC | $99.55 | 2025 | |
| Jazz Pharmaceuticals INC. | $48.50 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $17.64 | 2024 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.